Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SELLAS Life Sciences Group, Inc. - Common Stock (NQ:SLS)

3.630 -0.190 (-4.97%)
Streaming Delayed Price Updated: 1:20 PM EST, Feb 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,904,917
Open 3.810
Bid (Size) 3.630 (1,800)
Ask (Size) 3.640 (3,300)
Prev. Close 3.820
Today's Range 3.625 - 3.890
52wk Range 0.9516 - 5.176
Shares Outstanding 15,873,941
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
SLS Stock In Spotlight On EU Expansion For Cancer Therapy – Retail Says Potential Catalyst For Buyout ↗
The IMPACT-AML program will conduct a European clinical study evaluating SLS009 and provide SELLAS access to multiple clinical sites and a broader patient population. 
Via Stocktwits
SELLAS Life Sciences Falls For Fourth Straight Session — What’s Driving The Sell Off? ↗
Via Stocktwits

Performance

YTD
-16.6%
-16.6%
1 Month
-27.4%
-27.4%
3 Month
+116.1%
+116.1%
6 Month
+129.0%
+129.0%
1 Year
+143.6%
+143.6%

More News

Read More
News headline image
The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech
From Equity Insider
Via GlobeNewswire
Top movers analysis one hour before the close of the markets on 2026-01-06: top gainers and losers in today's session. ↗
Via Chartmill
Why Is SELLAS Life Sciences Stock Falling Today? ↗
Via Stocktwits
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
News headline image
Nasdaq, S&P 500 Futures Edge Lower Despite CES-Driven AI Optimism: Why NVDA, TSLA, AMD, AEVA, OS Are On Traders' Radar Today ↗
Via Stocktwits
Topics Artificial Intelligence ETFs Stocks
News headline image
SLS Stock Breaches $5 Level After Over 3 Years: Retail Now Eyes Buyout For As Much As $25B ↗
Via Stocktwits
Topics Death
News headline image
Why Is SLS Stock Drawing Significant Investor Attention Today? ↗
Via Stocktwits
Topics Death
News headline image
Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal
Via MarketMinute
Topics ETFs Intellectual Property
News headline image
SELLAS Life Sciences Group Stock Soars As It Nears Final Analysis In Cancer Study ↗
Via Stocktwits
Topics Death
News headline image
SLS Stock Has Risen 78% In A Month — What’s The Retail Buzz About? ↗
Via Stocktwits
News headline image
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
From Equity Insider
Via GlobeNewswire
News headline image
These stocks are gapping in today's session ↗
Via Chartmill
News headline image
SELLAS Life Sciences Stock Has Doubled This Year – Here’s Why Retail Investors Are Bullish ↗
Via Stocktwits
Topics Death
News headline image
SELLAS Life Sciences Draws Retail Buzz On SLS009 Trial Momentum – Stock Soars In Pre-Market ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
Via Benzinga
News headline image
Papa John's Is Not First: Here Are 3 Other Stocks Rocked By Market-Moving Fake News ↗
Via Benzinga
News headline image
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
Sellas Life Sciences Stock Jumps Over 7% Premarket: Buzz Builds Ahead Of Weekend Cancer Drug Presentation In Berlin ↗
Via Stocktwits
News headline image
SELLAS Life Sciences Stock Rises On Strong Preclinical Data For Investigational Cancer Treatment ↗
Via Stocktwits
News headline image
Sellas Life Sciences Stock In Spotlight After Institutional Investor Exercises Existing Warrants ↗
Via Stocktwits
News headline image
SELLAS Life Sciences Group Inc (NASDAQ:SLS) Reports Q2 2025 Earnings: Narrower Loss and Clinical Progress Amid Revenue Challenges ↗
Via Chartmill
News headline image
Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices
Via FinancialNewsMedia
News headline image
Thursday's after hours session: top gainers and losers ↗
Via Chartmill

Frequently Asked Questions

Is SELLAS Life Sciences Group, Inc. - Common Stock publicly traded?
Yes, SELLAS Life Sciences Group, Inc. - Common Stock is publicly traded.
What exchange does SELLAS Life Sciences Group, Inc. - Common Stock trade on?
SELLAS Life Sciences Group, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for SELLAS Life Sciences Group, Inc. - Common Stock?
The ticker symbol for SELLAS Life Sciences Group, Inc. - Common Stock is SLS on the Nasdaq Stock Market
What is the current price of SELLAS Life Sciences Group, Inc. - Common Stock?
The current price of SELLAS Life Sciences Group, Inc. - Common Stock is 3.630
When was SELLAS Life Sciences Group, Inc. - Common Stock last traded?
The last trade of SELLAS Life Sciences Group, Inc. - Common Stock was at 02/05/26 01:20 PM ET
What is the market capitalization of SELLAS Life Sciences Group, Inc. - Common Stock?
The market capitalization of SELLAS Life Sciences Group, Inc. - Common Stock is 57.62M
How many shares of SELLAS Life Sciences Group, Inc. - Common Stock are outstanding?
SELLAS Life Sciences Group, Inc. - Common Stock has 58M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.